Monitoring gastresophageal reflux in patients who underwent esophagectomy with gastric tube reconstruction using the Bravo wireless system

Monitoring gastresophageal reflux in patients who underwent esophagectomy with gastric tube reconstruction using the Bravo wireless system - Monitoring gastrsophageal reflux in the remnant esophagus using the pH monitoring wireless system

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004111

Enrollment

Registered

2010-09-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with no recurrence, who underwent esophagectomy for esophageal cancer with gastric tube reconstruction and can take orally

Interventions

pH monitoring in the remnant esophagus after esophagectomy using the wireless pH monitoring system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients who underwent esophagectomy with gastric tube for esophageal cancer 2. be able to take orally 3. with no recurrence 4. written informed consent

Exclusion criteria

Exclusion criteria: 1. with active other cancer 2. pacemakers or implantable cardiac defibrillators 3. bleeding diathesis 4. strictures, obstructions 5. severe varices esophagitis 6. severe esophagitis 7. severe liver/kidney/heart/lung disorder

Design outcomes

Primary

Measure	Time frame
1) adverse events defined by National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Scale	—

Countries

Japan

Contacts

Public ContactMiyazaki Yasuhiro

Osaka University Graduate School of Medicine Department of Gastroenterological Surgery

06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026